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ARTICLE OPEN
Attachment and antibiotic response of early-stage biofilms
studied using resonant hyperspectral imaging
Yue Wang 1✉, Christopher P. Reardon1, Nicholas Read2, Stephen Thorpe2, Adrian Evans3, Neil Todd3, Marjan Van Der Woude 4 and
Thomas F. Krauss1
Many bacterial species readily develop biofilms that act as a protective matrix against external challenge, e.g., from antimicrobial
treatment. Therefore, biofilms are often responsible for persistent and recurring infections. Established methods for studying
biofilms are either destructive or focus on the biofilm’s surface. A non-destructive method that is sensitive to the underside of the
biofilm is highly desirable, as it allows studying the penetration of antibiotics through the film. Here, we demonstrate that the high
surface sensitivity of resonant hyperspectral imaging provides this capability. The method allows us to monitor the early stages of
Escherichia coli biofilm formation, cell attachment and microcolony formation, in-situ and in real-time. We study the response of the
biofilm to a number of different antibiotics and verify our observations using confocal microscopy. Based on this ability to closely
monitor the surface-bound cells, resonant hyperspectral imaging gives new insights into the antimicrobial resistance of biofilms.
npj Biofilms and Microbiomes            (2020) 6:57 ; https://doi.org/10.1038/s41522-020-00169-1
INTRODUCTION
Biofilms are commonly defined as communities of surface-
attached microorganisms embedded in an extracellular matrix
that are attached to a surface. In most natural environments,
polymicrobial biofilms are predominant and their survival often
relies on intercellular communication and interactions1,2. In the
last few decades, biofilms have attracted great attention in areas
ranging from environmental studies to industrial water systems,
from the food industry to chronic infections3–6. In fact, 60–80% of
human bacterial infections, including many bloodstream and
urinary tract infections, are caused by bacterial biofilms7–10.
Biofilm-based infections are extremely difficult to cure, as biofilms
are intrinsically much less susceptible to antimicrobial agents than
non-adherent, planktonic cells. There are two main mechanisms
for antimicrobial tolerance in biofilms. The first is the failure of an
antimicrobial agent to diffuse and penetrate into the depth of the
biofilm. This is due to the extracellular polymeric matrix that forms
the biofilm and that is known to retard the diffusion of
antimicrobial agents11, and solutes in general. Hence the
substratum, i.e., the surface-bound underside of the biofilm,
remains protected. The second mechanism is that some of the
biofilm cells experience nutrient limitation and, therefore, exist in
a slow-growing or starved state8–14. Because of their much slower
metabolism, slow-growing or non-growing cells are more tolerant
of antimicrobial agents.
Recent studies have also shown that microorganisms growing
in a biofilm are highly resistant to antimicrobial agents15–19. The
antibiotic resistance in biofilms is generally caused by mutations
and is driven by the repeated exposure of the bacteria to high
levels of antibiotics as a consequence of treating the biofilm-
associated infections, for instance20,21. The minimum inhibitory
concentration (MIC), defined as the lowest concentration of an
antimicrobial that will inhibit the visible growth of a microorgan-
ism, is often considered as the “gold standard” for determining the
susceptibility of microorganisms to antimicrobials22,23. As a result
from both biofilm tolerance and antimicrobial resistance, it is
known that a subset of the sessile bacteria in biofilms can survive
in the presence of up to 1000 times MIC, compared to the
planktonic cells24,25.
To account for this discrepancy, new pharmacodynamic
parameters, such as the minimum biofilm inhibitory concentration
(MBIC) and the minimum biofilm eradication concentration
(MBEC) have been introduced. To evaluate antimicrobial activity
on sessile bacteria, in-vitro systems with abiotic surfaces have
been developed over the last decade24–27. Closed systems (batch
culture), such as multi-well plate assays, the Calgary device, and
open systems (continuous culture), such as substratum suspend-
ing reactors and the flow cell systems, are some of the most used
in-vitro biofilm models for susceptibility studies28, but they often
require staining and/or dissolving the biofilms for visualisation and
quantification, so they are typically destructive and do not allow
monitoring the progression of antimicrobial activity.
Despite all of the advances made in biofilm antimicrobial
resistance and tolerance studies, a highly sensitive system that is
able to monitor biofilm formation and dispersion in real-time, non-
destructively and quantitatively, is still missing. Monitoring the cell
attachment and colonisation stage is paramount to this effort, as it
allows for taking control of the early stages of biofilms and
developing strategies for the prevention of mature biofilm
formation. Similarly, monitoring the substratum of the biofilm is
essential for understanding when antimicrobial action is com-
pleted. To address this challenge, we introduce the technique of
resonant hyperspectral imaging to the monitoring of biofilms. We
demonstrate the real-time monitoring of cell attachment and the
development of micro-colonies of Escherichia coli (E. coli) bacteria
on the sensor surface with a range of initial inoculum density,
starting from 2 × 105 CFU per mL. Owing to the high surface
sensitivity of the guided-mode resonance we employ, we are able
to focus on the underside of the biofilm where antibiotic access is
most challenging. We are able to provide a clear picture of the
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early-stage of biofilm formation and of the response of the biofilm
to a range of antibiotics with varying doses. The unique
information provided by resonant imaging may support the
development of novel therapies for treating biofilm-associated
infections.
RESULTS
Hyperspectral images of early-stage biofilms
The key element of our biofilm sensor is a grating that supports a
guided-mode resonance (GMR)29. The grating is fabricated in a
150 nm thick silicon nitride (Si3N4) film on a glass substrate. Si3N4
has a high-refractive index to support the guided-mode, it exhibits
minimal absorption at visible and near-infrared wavelengths, and
most importantly, it is biocompatible, chemically inert and
mechanically robust30,31. We first simulate the grating design
using rigorous coupled-wave analysis (RCWA) and fabricate
structures with a period of 569 nm and a filling factor (defined
as the fraction of high-refractive index material in one period) of
80% for a resonance wavelength operating at 850 nm. The
evanescent tail of the guided-mode extends beyond the grating
layer and into the sensing region and thereby defines the
detection volume. The size of the detection volume is determined
by the difference between the effective index of the GMR and the
refractive index of the sensing region, as is apparent from
fundamental guided-mode theory32; the detection volume is
typically 100–200 nm in depth and only extends into the first
bacterial layer of the biofilm. Therefore, the sensor is able to
monitor the very early stages of biofilm formation and the biofilm
substratum, and is not susceptible to the background signal that
arises from the bulk biofilm and the surrounding media.
Figure 1 is a schematic drawing of the experimental setup. The
grating is placed into a flow cell to simulate the typical
environment of interest, for instance a water pipe or the inside
of the bladder, and to discourage settling of the bacteria. The flow
is generated by a peristaltic pump with sterile silicone tubes. We
used E. coli cultured in Luria-Bertani (LB) medium with an initial
concentration of 2 × 108 CFU per mL and kept the bacteria in a
37 °C water bath and flowed them through the sensor with a flow
rate of 5 mL s-1. Images from the sensor are formed hyperspec-
trally by taking a sequence of bright-field images that are typically
obtained in less than 3min depending on the camera’s
integration time (usually set to be 1 s) and the wavelength
resolution (usually set to be 0.2 nm), each at a different
illumination wavelength achieved via a tunable monochromatic
light source. For example, it takes just over 2 min for a scan of
25 nm wavelength range with 0.2 nm resolution, i.e., 125 images,
and a hyperspectral image of the resonance is then generated
within seconds. By analysing the intensity values of each bright-
field image, the resonance wavelength for each pixel can be
determined. By plotting the resonance wavelengths of all pixels in
the array, we produce the hyperspectral images of the grating at
resonance (for example in Fig. 2(a–d)). The resulting hyperspectral
image contains the spectral response at every pixel within the
microscope’s field of view. The region of interest (i.e., the centre of
the GMR grating) consists of 200 × 200 pixels on the camera
(corresponding to approximately 250 × 250 µm2 in size). We then
combine the resonance wavelengths of all 200 × 200 pixels in
each hyperspectral image as a histogram (see Fig. 2(e–h)), and by
fitting a Gaussian curve to this histogram, we obtain a central
resonance wavelength (λn) for each hyperspectral image. It is
worth nothing here that the distribution in the resonant
wavelengths at time 0, defined as λ0, arises predominately from
nanofabrication tolerances in a GMR grating. This uncertainty
follows a normal distribution33; hence, a Gaussian distribution is
used to determine the central resonant wavelength and the
resonance uniformity. Finally, the shift in the central resonance
wavelength (Δλ= λn – λi, while λi is defined as the base value of
the resonance wavelength, averaged over the first 30 min after the
flow of culture is started) caused by the refractive index change
given by the bacterial attachment and the formation of micro-
colonies, is plotted over time (see Fig. 2(i)). It appears that the shift
in resonant wavelength, Δλ, saturates after ~5 h, which indicates
that the first layer of the biofilm has been established (also see
Supplementary Figs. 1 and 2); while it is understood that the
biofilm continues to grow, the technique is not sensitive to further
increases in thickness. We also note here that in the plane of the
grating surface, the spatial resolution is 2 μm along the grating
grooves and 6 μm in the direction perpendicular to the grating
grooves34.
Biofilm formation as a function of bacterial concentration
Cultures of E. coli were diluted to different concentrations, ranging
from 2 × 105 to 2 × 108 CFU per mL. These dilutions were then
used in separate experiments to inoculate the sensor and to study
the rate of biofilm formation. We choose this range due to known
clinical practice, where a specimen is considered positive for
urinary tract infection in adults if the uropathogen concentration
is >105 CFU per mL35. We then set the sensor to obtain a
hyperspectral resonant image at intervals of 9 min. Figure 3(b–e)
shows that resonance wavelength shift is characteristic of early-
stage single species biofilm formation, which appears with a
similar shape of typical growth curves of planktonic cells36,
although the mechanisms behind the curves are rather different.
The biofilm formation profiles detected within a 15-h window can
be described by three phases. Initially, planktonic bacteria attach
to the surface —although some attachments are reversible
(named “planktonic” phase). The attached cells then aggregate
to form micro-colonies while excreting extracellular polymeric
substances, making their attachment irreversible (named “colo-
nies” phase). The bottom-layer of the biofilm is then considered
established and continues to mature into a multi-layered cluster
(“mature” phase). The “mature” phase, which can be upwards of
multiple micrometres in thickness, is beyond the detection
volume of our sensor and is, therefore, not “seen”, hence the
Fig. 1 Experimental setup. A broadband light source (SM30,
Leukos) combined with a grating-based monochromator is
employed to generate a single illumination wavelength with a
spectral width of 0.6 nm, which is then guided into an inverted
microscope with a 5x objective lens (Olympus NeoDplan). A GMR
grating is mounted on the bottom of a flow cell with PDMS; the flow
of E. coli culture is generated by a peristaltic pump with sterile
silicone tubes from a reservoir of culture in a 37 °C water bath. The
flow cell is used to avoid detection of the planktonic cells that
happened to land on the grating but are not involved in biofilm
formation. The camera used here is a CoolSnap Myo (Photometrics)
with 970 x 730 pixels. Images are captured using LabView, and
image analysis and curve fitting are performed using MATLAB.
Y. Wang et al.
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resonance wavelength shift, Δλ, saturates. It is also known that the
embedded biofilm cells do not divide and instead, their excess
energy is used to maintain the extracellular matrix11,37. This
explains why the resonance wavelength, i.e., the refractive index
on the sensor surface, remains constant after a certain period of
time.
A modified sigmoidal function is used to model the biofilm
formation curves, see Fig. 3. As discussed above, the characteristic
“S”-shaped biofilm formation curve appears similar to the typical
shape of planktonic bacterial growth curve, where sigmoidal
models, such as Gompertz model, are commonly employed in
analysis36,38. Our modified sigmoidal function can be expressed in
terms of the resonant wavelength shift, as follows:
Δλ ¼
1
1=Aþ exp½α  ðt  tplankÞ
; (1)
where A is the amplitude of the profile, tplank is the time duration
of the reversible cell attachment, which is indicated with a shaded
region in Fig. 3, and α is the biofilm formation rate. The
relationship between the bacterial seeding density and the
“planktonic” phase time tplank is discussed in Supplementary
Information (see Supplementary Fig. 3). Although it is intuitive that
a higher initial inoculum density leads to a shorter biofilm
formation time, the technique readily allows us to quantify this
formation time. More importantly, the technique allows us to
quantify the biofilm’s response to antibiotics, as discussed in the
next section.
Response of E. coli biofilms to antibiotics
Next, we use the sensor to study the response of biofilms to
antibiotic challenge, especially the response of the cells at the
bottom-layer of the biofilm. With monitoring the changes on the
grating surface, we aim to detect which antibiotic can effectively
disrupt the biofilm substratum. If the antibiotic causes a disruption
to the distribution of the biofilm substratum, or partial or full
detachment of the biofilm, we should observe a change in
resonance wavelength of the grating. We use a concentration of
2 × 108 CFU per mL in order to speed up the process; using this
concentration, the bottom-layer of the biofilm is typically
established within 5–6 h (see Supplementary Fig. 1 and 2). Our
real-time, non-destructive monitoring capability then allows us to
introduce antibiotics before, during and after a biofilm has been
formed on the sensor surface.
For uncomplicated lower urinary tract infections in adults,
current UK NICE (The National Institute for Health and Care
Excellence) guidelines recommend nitrofurantoin (which inhibits
the citric acid cycle, as well as synthesis of DNA, RNA, and protein,
Fig. 2 Hyperspectral images and resonance wavelength shifts. a–d Hyperspectral images generated by the biofilm sensor at times 0, 2, 3.5
and 6 h from the start of the experiment. The colour represents the resonance wavelength; e–h histogram data of resonance wavelengths of
all pixels in a–d correspondingly, and Gaussian fit (red curve) to determine the central wavelength: λ0 (at 0 h), λb (at 2 h), λc (at 3.5 h) and λd
(at 6 h); i plot of the resonance wavelength shift, Δλ (Δλ= λn–λi), against time (dots represent the central resonance wavelength λn from each
Gaussian fit; shaded areas illustrate standard deviations of corresponding Gaussian fits and delineates the distribution of the resonance
wavelengths of all 200 x 200 pixels) and the solid line is a sigmoidal fit to the data. λi is defined as the base value of the resonance wavelength,
averaged over the first 30min after the flow of culture is started. Data showing long term (45 h) stability of the biofilm sensor with fresh LB
media introduced into the flow cell at 24 h. The initial E. coli concentration used here is 2 × 108 CFU per mL.
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also a bactericidal antibiotic) and trimethoprim (a folic acid
synthesis inhibitor, a bacteriostatic antibiotic) as first line
antibiotics due to their low risk of microbial resistance39. We,
therefore, choose these two drugs as our model antibiotics. The
MIC and the minimum bactericidal concentration (MBC) were pre-
assayed with planktonic E. coli cells in 96-well plates (see
Supplementary Information and Supplementary Fig. 4 for details).
The MIC of trimethoprim for this strain is determined to be < 1 μg
mL−1 and the MBC as 16–32 μgmL−1. Trimethoprim with a dose
of 1 μgmL−1 is, therefore, introduced into the culture at times 0,
3.5 and 5.0 h. We make the following observations (Fig. 4):
● When the antibiotic is injected at time 0 h, it completely halts
cell attachments, and no colonisation and subsequent multi-
layered biofilm formation is observed on the sensor surface;
● When the antibiotic is added at 3.5 h, the colonies stop
developing immediately upon introduction of the drug,
halting any further establishment of the biofilm;
● When 1x MIC of trimethoprim is added at 5.0 h (after the
profile shows “saturation”), there is no observable change, i.e.,
the curve looks identical to the one without antibiotics added
(see Supplementary Information). This indicates that there is
no change, i.e., in terms of colony density or detachment, at
the bottom-layer of the biofilm.
In order to study the biofilm tolerance, we increase the dose of
trimethoprim from 1 to 500x MIC (equivalent to 20x MBC
approximately). The antibiotic solutions are administrated at 5 h
from the start of the experiments, i.e. after the monolayer of
biofilm is established. There is no significant effect on the
detected resonance wavelength at any dose (see Fig. 5(a) for
500x MIC and more details in Supplementary Fig. 5). As the sensor
probes the substratum of the biofilm, i.e., the volume that is in
direct contact with the grating, the results indicate that even with
extremely high doses of trimethoprim, the sensor does not detect
significant changes. A separate study on nitrofurantoin reveals
very similar results to trimethoprim (see Supplementary Fig. 6 for
more information). We can, therefore, conclude that nitrofurantoin
and trimethoprim are effective against planktonic cells, but not
against biofilms formed by the same strain.
Confocal fluorescence microscope images confirm our findings
(Fig. 5b, c, g, h). Following the addition of 500x MIC of
trimethoprim, introduced to the culture at 5 h, the biofilm is
allowed to continue “growing” for at least a further 5 h with the
antibiotic present. We observe that there is still a good bacterial
coverage on the grating after the multiple wash steps that are
required during the staining process, and the majority of cells
attached to the surface are still alive (Fig. 5c, and more confocal
fluorescence images in Supplementary Fig. 7). This confirms that
the bottom-layer of the biofilm is undisrupted, in agreement with
our sensor result. As clearly observed in Fig. 5(c), there are too
many surviving bacteria in the 500x MIC case that remain attached
to the sensor surface to consider this a biofilm eradication
concentration (MBEC). This observation indicates that the MBEC is
higher than 500x MIC, i.e., 0.5 mgmL−1 in this case, which is also
consistent with other reports employing fluorescent testing
methods24,25. Colony counting on agar plates after 24 h incubation
revealed that there are living cells in the remaining biofilms.
So our recognition that trimethoprim is not effective against
biofilms is confirmed by multiple control methods.
We then tested two other bactericidal antibiotics, i.e., rifampicin
(an RNA synthesis inhibitor, can be bacteriostatic or bactericidal
depending on concentrations) and ciprofloxacin (inhibits DNA
replication and exhibits both bacteriostatic and bactericidal
activities), and they have been suggested because of their efficacy
against biofilms. Identifying the best antimicrobials against
biofilms is an active area of research13,40,41 that may benefit from
a simple and real-time, non-destructive technique such as ours.
With our biofilm sensor, the disruption at the bottom of biofilm
is observed as a shift of the resonance wavelength shortly after
the administration of ciprofloxacin to a biofilm after 5 h of growth
(Fig. 5(f)). Confocal microscopy with the live/dead assay confirms
that the coverage of bacteria on the sensor surface is significantly
reduced, and the cells in one remaining colony attached to the
surface are also mostly dead (red colour) or injured with
compromised cell membranes (yellow colour), shown in Fig. 5
(h). This outcome is significantly different to what we observe with
the other antibiotics, even though the phase contrast images of all
Fig. 3 Biofilm formation time as a function of E. coli concentra-
tion. a LB broth only, for reference. Concentrations of (b) 2 × 105, (c)
2 × 106, (d) 2 × 107, (e) 2 × 108 CFU per mL in LB. At least three
independent replicates were performed for each concentration and
reference. The solid lines are sigmoidal fits to the data and the fitting
parameters are presented in Table 1. The shaded region indicates
the duration of the reversible cell attachment, tplank.
Fig. 4 Antimicrobial susceptibility testing in early-stage biofilms.
A 1x MIC dose of trimethoprim is introduced to the culture at 0 h
and at 3.5 h (as indicated by the vertical dashed lines). The solid
black line is a sigmoidal fit to the data. After introducing the
antibiotic, the data are fit to a straight line.
Y. Wang et al.
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these samples are rather similar (Fig. 5d–e and i–j). The phase
contrast images include not only the cells attached to the surface,
but also the biofilm cells that are detached from the surface but
near the surface, as well as some planktonic cells. In contrast,
confocal microscopy with the Live/Dead staining involves a few
washing steps during the process (see “Methods”), therefore, the
confocal images represent the biofilm cells that are still firmly
attached to the sensor surface. In Fig. 5f, it certainly appears that
300x MIC ciprofloxacin results in a rapid and significant disruption
on the bottom of the biofilm. Indeed, this disruption seems to
cease after 5 h and our hypothesis is that ciprofloxacin causes
removal of majority of the biofilm on the sensor surface, leaving a
small number of cells possibly with some exocellular matrix
remaining on the surface, which is reflected by a small resonance
wavelength shift after 10 h in Fig. 5(f). In short, our GMR sensor,
compared to the conventional microscopic techniques, provides a
non-destructive, rapid, dynamic sensing and analysis technique,
which can provide real-time information of the very bottom of
biofilm.
For ease of comparison and reproducibility, all of these studies
have been performed in LB broth and each set of experiments has
been repeated for a minimum of three times. We have also
performed total biofilm removal experiments with 70% ethanol
wash followed by a piranha etch (a 3:1 mixture of sulfuric acid and
30% hydrogen peroxide). This protocol removes any organic
residues on the grating surface including the extracellular matrix.
A total recovery of the original resonance wavelength is observed,
which indicates that complete removal of biofilms can be
detected by our sensor. To ensure clinical relevance, we have
also demonstrated that the technique is compatible with
undiluted human urine (see Supplementary Fig. 8).
DISCUSSION
In summary, we have introduced the technique of resonant
hyperspectral imaging to monitoring the formation of Escherichia
coli biofilms and have studied the response of these biofilms to a
range of antibiotics. The key aspect that makes the technique so
suitable for studying biofilms is that it only images the first few
100 nm from the bottom, i.e., the substratum, of the biofilm, which
is the most important section of the film in terms of both early
formation and antibiotic challenge. As the technique is only
sensitive to the substratum, the sensing signal is not affected by
the media, the thickness of the biofilm or to any planktonic cells
suspended in the media, so it is easy to achieve a high signal to
noise ratio. Furthermore, within the same assay, a quantitative
indication of the bacteria concentration can be readily obtained
by monitoring the time it takes for the onset of biofilm formation.
Given this real-time monitoring capability, the technique also
allows antimicrobial resistance testing in-situ, therefore offering
the opportunity of quantitatively analysing the action and
progression of different antibiotics against the biofilm within
minutes to a few hours. The non-destructive nature of the
technique is a unique advantage, compared to, e.g., fluorescence-
based microscopy techniques.
We envisage that our system can be miniaturised into a hand-
held device that could be implemented as a diagnostic within a
clinical environment; such a realisation would allow for, e.g., the
tailoring of antibiotic therapies to individual patients. Alternatively,
the technique could be used for in-field biofilm detection, such as
within water treatment plants or domestic water delivery pipes,
food processing plants and equipment, heating, ventilation, and
air-conditioning (HVAC) systems etc.. One can also envisage
further improvements in terms of response time by accelerating
bacterial attachment by using antibodies or carbohydrate coatings
such as mannose. Undoubtedly, in a real biological or industrial
system, the environment is far more complicated and polymicro-
bial biofilms tend to dominate. Although the polymicrobial nature
of biofilms would not limit the performance of our sensor,
additional sample or surface treatments may be used with our
sensing system in order to improve specificity. For instance, pre-
filtering or surface functionalisation could be employed in biofilm
Fig. 5 Three different techniques to monitor biofilms: GMR sensor (left), confocal fluorescence microscope (middle), and phase contrast
microscope (right). Trimethoprim (final dose of 500x MIC, a–e) and ciprofloxacin (final dose of 300x MIC, f–j) injected at 5 h (dashed line) from
the beginning of the experiment and microscopic images are obtained after 10 h (dash dotted line) from the start of the experiments.
Confocal microscopic images (b, c and g, h) and phase contrast images (d, e and i, j) are all taken at 10 h from the start of the experiments;
c and h, e and j are confocal and phase contrast images of biofilms with antibiotic injected at 5 h from the start of the experiments,
respectively; The scale bars in the micrographs are all 10 μm long.
Y. Wang et al.
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related bloodstream infection studies in order to gain some
insight on the roles of each species in a biofilm community.
Reports have also shown that the growth dynamics of a
polymicrobial biofilm involve some extra phases42, which can be
further explored using our sensor system in future work.
Overall, we believe that our technique may be widely applicable
both in industry and healthcare for fundamental studies and for
applications that require the detection and monitoring of biofilms.
With its high sensitivity to any changes in the substratum of
biofilms, our sensor can be used in conjunction with other
conventional techniques in order to gain a comprehensive
understanding of biofilm formation, tolerance and antimicrobial
resistance.
METHODS
Bacterial strain and growth conditions
E. coli K-12 carrying the F conjugative plasmid, also known as E. coli TG1, is
chosen in this work as it has been shown previously to promote thick,
mature biofilms within a short period of time43,44. A single colony is
inoculated into a test tube containing 25mL of liquid Luria-Bertani (LB)
broth and placed in an orbital rotating shaker at 4 x g overnight at 37 °C.
Some of this culture is then transferred and diluted within a fresh tube of
LB broth to obtain the required concentrations of the microbial
suspension. Optical density (OD) measurements are performed alongside
separate cell counting on LB agar plates to determine bacterial
concentrations. For example, OD600nm= 0.2 corresponds to a 2 × 10
8 CFU
per mL concentration.
Fabrication of resonance gratings and flow cell
In order to fabricate the gratings, a 150 nm Si3N4-on-glass substrate is
cleaned in a piranha solution (hydrogen peroxide: sulfuric acid= 1:3 ratio),
rinsed in acetone and isopropanol, and dried with nitrogen. The substrate
is then coated with e-beam resist (ARP-13, AllResist GmbH), spun at 280 x g
for 60 s, and baked at 180 °C for 10min, resulting in a film of approximately
400 nm. For charge dissipation during e-beam exposure, a thin film of
aluminium (20 nm) is deposited on top of the resist using a thermal
evaporator (HEX, Mantis). The grating pattern is defined in the e-beam
resist using an electron beam lithography system (Raith GmbH Voyager
50 kV), followed by pattern transfer into the substrate using reactive ion
etching with a gas mixture of CHF3 and O2. The depth of the grating in the
substrate is 150 nm. The aluminium layer is removed in phosphoric acid
and the residue of e-beam resist is removed with Microposit resist remover
1165 (MicroChem). The fabricated grating is then fixed to the bottom of a
sterile quartz glass container. The flow of E. coli culture is generated by a
peristaltic pump with sterile silicone tubes from a reservoir of culture,
typically a total of 40 mL, in a 37 °C water bath. Each set of experiments
(including each E. coli concentration, references, each antibiotic and
different concentrations) were repeated a minimum of three
independent times.
Live/dead staining and confocal microscopy
After a certain time of growth, the grating is taken out from the flow cell,
gently washed with phosphate buffered saline (PBS) buffer (Sigma-
Aldrich) three times to remove the remains of the medium and planktonic
cells, as well as loosely attached non-biofilm cells, and then incubated for
15 min in the dark with the BacLight Live/Dead viability kit (Thermo Fisher
Scientific) to stain the cells with two fluorescent dyes, SYTO® 9 (green) and
propidium iodide (red). Samples were then rinsed twice with PBS buffer
and sealed under a coverslip. The stained biofilms on the grating are
visualised using a ZEISS LSM 880 Confocal Microscope with a plan
apochromat 63x oil-immersion objective. The Live/Dead viability kit stains
live cells green, dead cells red and some cells appear yellow or orange
indicating that those bacteria are injured with possibly compromised cell
membranes45.
Antibiotic preparation and MIC assay
Stock solution of 10mgmL−1 of four antibiotics, i.e. trimethoprim,
nitrofurantoin, rifampicin and ciprofloxacin (Sigma-Aldrich), are prepared
by dissolving in dimethyl sulfoxide, diluting in deionized water and filter
sterilising (0.22 µm syringe filter, Fisher Scientific). A microdilution assay
was also performed on 96-well plates by exposing E. coli TG1 to a serial
dilution of trimethoprim, nitrofurantoin, rifampicin and ciprofloxacin, in
order to determine the MIC of each drug. The reporter dye resazurin was
added to indicate the viability status of the cells46. For more details on the
protocol, see Supplementary Information. The MIC measurements were
performed with OD= 0.2, i.e., 2 × 108 CFUmL−1, and repeated for
four times.
Bacteria-spiked urine sample
For the bacteria-spiked urine sample shown in Supplementary Information,
an overnight-grown suspension of E. coli cells in LB broth is centrifuged at
14,000 x g for 10 min, and washed in syringe-filtered human urine (0.22 µm
filter, Fisher Scientific). This process is repeated three times. Then the E. coli
cells are resuspended in syringe-filtered human urine and the final
concentration is made to be 2 × 108 CFU per mL in urine.
Reporting summary
Further information on research design is available in the Nature Research
Reporting Summary linked to this article.
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